Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.
作者信息
Xu Fengrui, Jiang Zefei
机构信息
Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
出版信息
Ann Transl Med. 2020 Feb;8(4):138. doi: 10.21037/atm.2019.12.50.
Abstract
摘要
相似文献
1
Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.乳腺癌化疗骨髓毒性的预防：更个体化且更安全。
Ann Transl Med. 2020 Feb;8(4):138. doi: 10.21037/atm.2019.12.50.
2
Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.乳腺癌化疗骨髓毒性预防的勘误：更个体化且更安全。
Ann Transl Med. 2020 May;8(10):658. doi: 10.21037/atm-2020-21.
3
High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.大剂量化疗及自体骨髓或干细胞移植与传统化疗治疗早期预后不良乳腺癌女性的对比研究
Cochrane Database Syst Rev. 2016 May 20;2016(5):CD003139. doi: 10.1002/14651858.CD003139.pub3.
4
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.高剂量化疗及自体骨髓或干细胞移植与传统化疗治疗转移性乳腺癌女性的比较
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD003142. doi: 10.1002/14651858.CD003142.pub2.
5
Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.在一个大型基于人群的老年乳腺癌和卵巢癌女性队列中，化疗的使用与骨髓抑制风险的关系。
Med Oncol. 2011 Sep;28(3):716-25. doi: 10.1007/s12032-010-9512-5. Epub 2010 Apr 2.
6
Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study.原发粒细胞集落刺激因子预防对接受多西他赛加环磷酰胺辅助化疗的中国乳腺癌患者中性粒细胞毒性和化疗剂量给予的影响：一项回顾性队列研究。
Hong Kong Med J. 2022 Dec;28(6):438-446. doi: 10.12809/hkmj219439. Epub 2022 Oct 20.
7
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.大剂量化疗及自体骨髓或干细胞移植与传统化疗治疗转移性乳腺癌女性的比较
Cochrane Database Syst Rev. 2003(1):CD003142. doi: 10.1002/14651858.CD003142.
8
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.自体骨髓移植患者在标准抗菌预防基础上加用革兰氏阳性菌预防的随机试验。
Antimicrob Agents Chemother. 1994 Mar;38(3):576-9. doi: 10.1128/AAC.38.3.576.
9
Individualized chemotherapy guided by the expression of and genes versus classic chemotherapy in the treatment of breast cancer: A comparative effectiveness study.与传统化疗相比，基于 和 基因表达的个体化化疗在乳腺癌治疗中的效果：一项比较有效性研究。 （你提供的原文中“ 和 ”部分内容缺失，请补充完整以便准确翻译。）
Oncol Lett. 2021 Jan;21(1):21. doi: 10.3892/ol.2020.12282. Epub 2020 Nov 9.
10
Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.长链欧米伽-3 多不饱和脂肪酸补充剂可预防阿霉素和环磷酰胺化疗引起的雌性大鼠骨髓损伤。
Int J Mol Sci. 2018 Feb 6;19(2):484. doi: 10.3390/ijms19020484.
引用本文的文献
1
Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer.乳腺癌化疗骨髓毒性预防的勘误：更个体化且更安全。
Ann Transl Med. 2020 May;8(10):658. doi: 10.21037/atm-2020-21.
本文引用的文献
1
A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available.一种用于化疗相关中性粒细胞减少症一级预防的新型聚乙二醇化非格司亭生物类似药——美卡非格司亭现已上市。
Ann Transl Med. 2020 Mar;8(5):166. doi: 10.21037/atm.2019.10.61.
2
Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.甲磺酸培非格司亭预防乳腺癌患者化疗引起的中性粒细胞减少症的疗效和安全性：一项随机、多中心、活性药物对照的III期试验
Ann Transl Med. 2019 Sep;7(18):482. doi: 10.21037/atm.2019.07.95.
3
Physician attitudes about cost consciousness for breast cancer treatment: differences by cancer sub-specialty.医生对乳腺癌治疗成本意识的态度：癌症亚专科的差异。
Breast Cancer Res Treat. 2019 Jan;173(1):31-36. doi: 10.1007/s10549-018-4976-7. Epub 2018 Sep 26.
4
Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.曲妥珠单抗在资源有限或资源丰富地区的使用差异及其对 HER2 阳性乳腺癌的生存获益：来自中国的真实世界研究。
Oncologist. 2017 Nov;22(11):1333-1338. doi: 10.1634/theoncologist.2017-0088. Epub 2017 Aug 10.
5
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.紫杉醇治疗老年转移性乳腺癌的疗效和毒性：CALGB9342 和 9840 联合分析。
Ann Oncol. 2012 Mar;23(3):632-638. doi: 10.1093/annonc/mdr297. Epub 2011 Jun 21.
Zotero 插件